Annual Total Debt
$65.36 M
-$12.02 M-15.53%
December 31, 2024
Summary
- As of March 10, 2025, ABCL annual total debt is $65.36 million, with the most recent change of -$12.02 million (-15.53%) on December 31, 2024.
- During the last 3 years, ABCL annual total debt has risen by +$25.30 million (+63.14%).
- ABCL annual total debt is now -20.54% below its all-time high of $82.26 million, reached on December 31, 2022.
Performance
ABCL Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$65.36 M
-$6.04 M-8.45%
December 31, 2024
Summary
- As of March 10, 2025, ABCL quarterly total debt is $65.36 million, with the most recent change of -$6.04 million (-8.45%) on December 31, 2024.
- Over the past year, ABCL quarterly total debt has dropped by -$6.04 million (-8.45%).
- ABCL quarterly total debt is now -22.22% below its all-time high of $84.03 million, reached on June 30, 2023.
Performance
ABCL Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
ABCL Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.5% | -8.4% |
| 3 y3 years | +63.1% | -8.4% |
| 5 y5 years | +848.5% | -8.4% |
ABCL Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.5% | +63.1% | -22.2% | +77.7% |
| 5 y | 5-year | -20.5% | +1388.9% | -22.2% | -100.0% |
| alltime | all time | -20.5% | +1798.7% | -22.2% | -100.0% |
AbCellera Biologics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $65.36 M(-15.5%) | $65.36 M(-8.5%) |
| Sep 2024 | - | $71.40 M(-0.9%) |
| Jun 2024 | - | $72.05 M(-2.1%) |
| Mar 2024 | - | $73.61 M(-4.9%) |
| Dec 2023 | $77.38 M(-5.9%) | $77.38 M(-4.2%) |
| Sep 2023 | - | $80.76 M(-3.9%) |
| Jun 2023 | - | $84.03 M(+1.1%) |
| Mar 2023 | - | $83.13 M(+1.1%) |
| Dec 2022 | $82.26 M | $82.26 M(+8.1%) |
| Sep 2022 | - | $76.11 M(+106.9%) |
| Jun 2022 | - | $36.78 M(-8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $40.28 M(+0.5%) |
| Dec 2021 | $40.06 M(+812.6%) | $40.06 M(+33.3%) |
| Sep 2021 | - | $30.06 M(-9.6%) |
| Jun 2021 | - | $33.24 M(+79.6%) |
| Mar 2021 | - | $18.51 M(+321.5%) |
| Dec 2020 | $4.39 M(-36.3%) | $4.39 M(-17.6%) |
| Sep 2020 | - | $5.33 M(>+9900.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $6.89 M(+100.2%) | $6.89 M |
| Dec 2018 | $3.44 M | - |
FAQ
- What is AbCellera Biologics annual total debt?
- What is the all time high annual total debt for AbCellera Biologics?
- What is AbCellera Biologics annual total debt year-on-year change?
- What is AbCellera Biologics quarterly total debt?
- What is the all time high quarterly total debt for AbCellera Biologics?
- What is AbCellera Biologics quarterly total debt year-on-year change?
What is AbCellera Biologics annual total debt?
The current annual total debt of ABCL is $65.36 M
What is the all time high annual total debt for AbCellera Biologics?
AbCellera Biologics all-time high annual total debt is $82.26 M
What is AbCellera Biologics annual total debt year-on-year change?
Over the past year, ABCL annual total debt has changed by -$12.02 M (-15.53%)
What is AbCellera Biologics quarterly total debt?
The current quarterly total debt of ABCL is $65.36 M
What is the all time high quarterly total debt for AbCellera Biologics?
AbCellera Biologics all-time high quarterly total debt is $84.03 M
What is AbCellera Biologics quarterly total debt year-on-year change?
Over the past year, ABCL quarterly total debt has changed by -$6.04 M (-8.45%)